Cresnisol N18 inf. sol. i.v.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Alanine 16 g/l; Arginine 10,9 g/l; Aspartic Acid 3,2 g/l; Glutamic Acid 5,53 g/l; Glycine 7,68 g/l; Histidine 6,6 g/l; Isoleucine 5,53 g/l; Leucine 7,68 g/l; Lysine Acetate 12,2 g/l - Eq. Lysine 8,64 g/l; Methionine 5,53 g/l; Phenylalanine 7,68 g/l; Proline 6,6 g/l; Serine 4,38 g/l; Threonine 5,53 g/l; Tryptophan 1,85 g/l; Tyrosine 0,28 g/l; Valine 7,08 g/l

Available from:

Baxter SA-NV

ATC code:

B05BA01

INN (International Name):

Alanine; Arginine; Aspartic Acid; Glutamic Acid; Glycine; Histidine; Isoleucine; Leucine; Lysine Acetate; Methionine; Phenylalanine; Proline; Serine; Threonine; Tryptophan; Tyrosine; Valine

Pharmaceutical form:

Solution for infusion

Composition:

Alanine 16 g/l; Arginine 10.9 g/l; Aspartic Acid 3.2 g/l; Glutamic Acid 5.53 g/l; Glycine 7.68 g/l; Histidine 6.6 g/l; Isoleucine 5.53 g/l; Leucine 7.68 g/l; Lysine Acetate 12.2 g/l; Methionine 5.53 g/l; Phenylalanine 7.68 g/l; Proline 6.6 g/l; Serine 4.38 g/l; Threonine 5.53 g/l; Tryptophan 1.85 g/l; Tyrosine 0.28 g/l; Valine 7.08 g/l

Administration route:

Intravenous use

Therapeutic area:

Amino Acids

Product summary:

CTI code: 583244-01 - Pack size: 6 x 1000 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583235-01 - Pack size: 12 x 500 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2021-04-19